GENE ONLINE|News &
Opinion
Blog

2026-06-02|

Voya Investment Management Launches Multi-Manager Collective Investment Trusts for Institutional Investors

by GOAI
Share To

Voya Investment Management announced the launch of a new suite of multi-manager collective investment trusts (CITs) on Tuesday, June 2, 2026. These investment vehicles provide institutional investors with access to alternative investment strategies managed by a variety of external sub-advisors.

The new CITs aim to offer diversified exposure to alternative asset classes within a single investment structure. By utilizing a multi-manager approach, Voya Investment Management delegates the management of specific portfolio segments to different investment firms, which the company selects to oversee distinct strategies. These trusts function as tax-exempt investment vehicles primarily designed for retirement plans and other institutional investors seeking to incorporate alternative assets into their portfolios. The firm structured these offerings to provide institutional clients with additional options for managing risk and pursuing returns outside of traditional equity and fixed-income markets.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 2, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Insilico Medicine’s ISM8969 Enters Phase 1 Trial, Advancing Brain-Penetrant NLRP3 Inhibitor for Neuroinflammation and CNS Disorders
2026-06-18
PNC Multifamily Capital Launches $251.4 Million Affordable Housing Investment Fund
2026-06-18
ArcelorMittal, thyssenkrupp, and voestalpine Call for EU Emissions Trading System Reforms to Protect Steel Competitiveness
2026-06-18
Hillman Group and Hillwood Begin Construction on Dallas-Fort Worth Multipurpose Facility
2026-06-18
Six Taipei Biotechs Head to BIO 2026 in San Diego, With Precision Medicine, Drug Delivery, and Bioprocess Innovation in Focus
2026-06-18
2026 Tang Prize in Biopharmaceutical Science Honors Three Pioneers of “Living Drug” Immunotherapies
2026-06-17
How One South Korean Hospital Built a Global Reputation Around a $5 Billion Surgical Standard
2026-06-16
Scroll to Top